Alberta Blue Cross's 2026 drug pipeline report says GLP-1 receptor agonists remain a major cost driver for private plans and that overall GLP-1 therapy plan spend is unlikely to decline in future years, even as a semaglutide generic is expected in mid-2026
Barde YA, Edgar D, Thoenen H
The power is probably the most important part to understand
It is FDA-approved under three brand names: Wegovy (for weight loss), Ozempic (for type 2 diabetes) and Rybelsus (an oral form for diabetes)
These definitive findings underscore L-carnitine's vital, irreplaceable role in supporting heart muscle energy, which is a critical consideration for patients desperately trying to manage the severe cardiovascular symptoms of dysautonomia and POTS
Disposal: Discharge fully by leaving connected to a light load, then submerge in salt water for 2 weeks before disposing in an e-waste bin